Pharmaceutical Business review

nSpire Health to relocate its corporate headquarters

The modern facility and $2 million redesign investment accommodates nSpire Health’s growing staff, implementation of lean manufacturing on new manufacturing lines, respiratory core lab facilities, customer care and data center, and training center for its hospital and pharmaceutical company customers.

Michael Sims, president and CEO of nSpire, said: “We expect to improve productivity by having our US design, product development, administrative, sales, and marketing functions under one roof in a first-class facility. The move also provides for enhanced support to nSpire Health’s satellite facilities in the UK and Germany, which continue to play an important role in our growth strategy.”